Management of HER2-Positive Early Breast Cancer

被引：0
|
作者：
Steger, Guenther [1 ]
Lueftner, Diana [2 ]
Stoeger, Herbert [3 ]
Thurlimann, Beat [4 ]
Untch, Michael [5 ]
机构：
[1] Med Univ Wien, Univ Klin Innere Med 1, Klin Abt Onkol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Charite Campus Benjamin Franklin, Med Klin Schwerpunkt Hamatol Onkol & Tumorimmunol, Berlin, Germany
[3] LKH Univ Klinikum Graz, UKIM, Klin Abt Onkol, Graz, Austria
[4] Kantonsspital St Gallen, Brustzentrum, St Gallen, Switzerland
[5] Helios Klinikum Berlin Buch, Klin Gynakol & Geburtshilfe, Berlin, Germany
来源：
BREAST CARE | 2018年 / 13卷 / 06期
关键词：
D O I：
10.1159/000494945
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：453 / 455
页数：3
相关论文
共 50 条
  • [1] Advances in the management of HER2-positive early breast cancer
    Baselga, Jose
    Coleman, Robert E.
    Cortes, Javier
    Janni, Wolfgang
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 119 : 113 - 122
  • [2] ADVANCES IN THE MANAGEMENT OF HER2-POSITIVE BREAST CANCER
    Goel, Shom
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 68 - 68
  • [3] Optimizing the management of HER2-positive early breast cancer: the clinical reality
    Verma, Su.
    Lavasani, S.
    Mackey, J.
    Pritchard, K.
    Clemons, M.
    Dent, S.
    Latreille, J.
    Lemieux, J.
    Provencher, L.
    Verma, Sh.
    Chia, S.
    Wang, B.
    Rayson, D.
    CURRENT ONCOLOGY, 2010, 17 (04) : 154 - 167
  • [4] The management of HER2-positive early breast cancer: Current and future therapies
    Chen, Julia
    Colosimo, Maree
    Lim, Elgene
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 3 - 12
  • [5] Endpoint selection in HER2-positive early breast cancer
    Amir, Eitan
    LANCET ONCOLOGY, 2019, 20 (03): : 315 - 316
  • [6] HER2-positive breast cancer
    Loibl, Sibylle
    Gianni, Luca
    LANCET, 2017, 389 (10087): : 2415 - 2429
  • [7] Optimizing the Management of Metastatic HER2-Positive Breast Cancer
    Goel S.
    Tolaney S.
    Current Breast Cancer Reports, 2015, 7 (4) : 190 - 202
  • [8] Increasing therapy options for HER2-positive early breast cancer
    Harbeck, Nadia
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (01) : 10 - 12
  • [9] Adjuvant Chemotherapy for the Treatment of HER2-Positive Early Breast Cancer
    Clavarezza, Matteo
    Venturini, Marco
    ONCOLOGY, 2009, 77 : 14 - 17
  • [10] Trastuzumab and Vinorelbine in Early Stages of HER2-Positive Breast Cancer
    Ferrario, C.
    Wong, A.
    Gao, T.
    Bouganim, N.
    Aloyz, R.
    Panasci, L. C.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (01) : 32 - 35
12345